EUPATI Expert Training Course
September 2017 – December 2018
Deadline 31 March 2017 – Online application
The EUPATI Training Course Patient Experts in Medicines Research & Development is an exciting and unique opportunity offering patient advocates expert-level training in medicines research and development, specifically tailored for them.
When you have completed this course, we hope you will have the knowledge to make a meaningful contribution to the medicines research and development process to provide better medicines to patients. You will also be able to generate a broader dialogue around future patient involvement in the medicines research and development process across Europe.
The course will be a mixture of online and face-to-face education modules over a 14 month period, containing the following modules:
- Discovery of Medicines & Planning of Medicines Development
- Non-Clinical Testing and Pharmaceutical Development
- Exploratory and Confirmatory Clinical Development
- Clinical Trials
- Regulatory Affairs, Medicinal Product Safety, Pharmacovigilance and Pharmacoepidemiology
- Health Technology Assessment Principles and practices
The EUPATI project has organised two rounds of the Patient Expert Course, giving around 100 patients and patient advocates the chance to be trained on the medicines’ research and development process. The first round began in October 2014 and finished in December 2015. The second round started on 22 September 2015 and ended on 30 November 2016.
The third cycle of the EUPATI Training Course will run from September 2017 - December 2018. It is important for you to know that this course is to be taken entirely online with the exception of the two face-to-face sessions taking place in Barcelona on 26 February-2 March 2018 and 17-21 September 2018.
All lessons include videos and links which are not accessible without the use of the Internet. It is important that you have access to a computer and a high-speed Internet connection to be able to take the course successfully. No hard copy materials for the online components will, therefore, be printed out or otherwise provided to participants! This course has been designed as a living e-Learning course (meaning that we will make changes if we find that this makes the course better and easier for you to follow)
Throughout the course we will provide you with an online Course Advisor who will support you with any questions about the lessons and your progress.
Incomplete applications and/or applications received after the deadline of 31 March 2017, 23:59 Central European Time will not be looked at by the application committee
The application form contains the following sections. Please make sure that you complete all parts of the form.
- Content of the course
- Declaration of Commitment
- Face-to-Face training sessions
- Applicant’s General Information
- Experience in medicines research & development
- Experience in the EUPATI Specific Profiles
- Commitment to applying learning acquired
- Specific Requirements
- Certification and Acknowledgements
- Data Protection
The application form can be complete at: http://www.formdesk.com/epf/EUPATI3
Please refer to the Guide for Applicants for further details.
Who should apply?
The EUPATI Patient Expert Training Course has been specifically designed to meet the needs of patients and patient advocates who have the motivation and skill-set to be able to learn and apply expert-level knowledge across the whole spectrum of the medicine research and development process.
You should apply if you meet all the following requirements:
|Profile||Applicants must be either be a:|
Please note the list is not in any order of importance.
|Country of residence||Applications will be accepted from candidates living in the European Region according to the WHO definition, available here|
|Knowledge of medicines research and development and willingness to use the learning in practice||This course is designed for those who have a high level of interest in medicines’ research and development and would like to further develop and use that knowledge.|
Because of this, the topics are complex and therefore the course content as well - it is preferable that applicants have at least a basic knowledge and understanding of medicines research and development processes.
This course is open to all eligible individuals who have a high level of interest in this area, regardless of their current level of knowledge and experience.
However if you do sign up for this course we expect you to commit yourself to applying the knowledge in practice by becoming actively involved in medicines’ R&D after finishing the course.
|Time Commitment||Applicants must be able to commit to:|
|Language||The online lessons and their online assessments will be available in English only.|
The two face-to-face sessions will require a high level of interaction and communication in English.
To successfully take part in this course, you, therefore, must have a working knowledge of the language at least an Upper Intermediate level (B2 of the Common European Framework of Reference for Languages), meaning:
“You can interact with a degree of fluency and spontaneity that makes regular interaction with native speakers quite possible without problems to understand each for either party. You can write clear, detailed text on a wide range of subjects”.
- A Guide for Applicants v3
Size: 300,336 bytes, Format: .pdf
A guide for applicants thinking of applying for the third cycle of the EUPATI Training Course for Patient Experts in Medicines Research & Development.